Bio-XCell, a custom-built biotechnology park in Malaysia, has been set up in order to strengthen the country's infrastructure, ecosystem, and to draw global attention. The park aims to promote industrial and healthcare biotechnology manufacturing and research and development activities in the country. Jointly developed by the Malaysian Biotechnology Corporation and UEM Land Holdings, Bio-XCell is enabling development of a supportive biotechnology ecosystem around strategic anchor tenants.

Mr Rizatuddin Ramli, who was appointed as the CEO of Bio-XCell in October 2011, has taken the charge of delivering the objectives of phase II of the National Biotechnology Policy. The policy is aimed to bring science closer to business and would enable the biotechnology ecosystem to attract global investments.

In an interview with BioSpectrum, Mr Ramli talks about the growth strategies he will employ how Bio-XCell can contribute to the Malaysian biotechnology industry.

What changes and improvements are you implementing in Bio-XCell?

Mr Ramli: We have clear targets. We must focus on efficient delivery. We will be strengthening collaboration with agencies, build partnerships with both public and private sectors in optimizing resources that will help us have an edge in this biotechnology ecosystem that we are building.